Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1225 of 3173 entries
View as:

Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03460977 Org: User:
Start: 04/17/18 End: 03/19/26 Due: 03/19/27

Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.

Phase: N/A Priority: Normal
NCT ID: NCT04973826 Org: User:
Start: 08/20/21 End: 09/27/21 Due: 09/27/22

A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803

Phase: N/A Priority: Normal
NCT ID: NCT05286281 Org: User:
Start: 03/31/22 End: 05/26/22 Due: 05/26/23

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

Phase: N/A Priority: Normal
NCT ID: NCT00650624 Org: User:
Start: 06/30/03 End: 01/31/04 Due: 01/31/05

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03593707 Org: User:
Start: 08/17/18 End: 02/13/19 Due: 02/13/20

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Phase: N/A Priority: Normal
NCT ID: NCT00543439 Org: User:
Start: 12/31/07 End: 04/30/18 Due: 04/30/19

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02743871 Org: User:
Start: 04/27/16 End: 03/09/21 Due: 03/09/22

Bioavailability Study of PF-06651600 Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04004663 Org: User:
Start: 07/15/19 End: 10/11/19 Due: 10/11/20

Extension Study Of Tanezumab In Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00809783 Org: User:
Start: 02/06/09 End: 06/23/11 Due: 06/23/12

A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

Phase: N/A Priority: Normal
NCT ID: NCT02205476 Org: User:
Start: 12/31/14 End: 01/31/15 Due: 01/31/16

Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01658176 Org: User:
Start: 01/31/13 End: 04/30/15 Due: 04/30/16

Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Phase: N/A Priority: Normal
NCT ID: NCT00832650 Org: User:
Start: 04/30/09 End: 12/31/09 Due: 12/31/10

An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin

Phase: N/A Priority: Normal
NCT ID: NCT00776659 Org: User:
Start: 12/31/08 End: 09/30/12 Due: 09/30/13

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00471172 Org: User:
Start: 08/31/04 End: 05/31/05 Due: 05/31/06

Smoking Cessation Study In Healthy Adolescent Smokers

Phase: N/A Priority: Normal
NCT ID: NCT01312909 Org: User:
Start: 04/30/11 End: 01/31/18 Due: 01/31/19

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Phase: N/A Priority: Normal
NCT ID: NCT01465802 Org: User:
Start: 12/26/11 End: 05/18/15 Due: 05/18/16

Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan

Phase: N/A Priority: Normal
NCT ID: NCT00757575 Org: User:
Start: 02/29/08 End: 10/31/10 Due: 10/31/11

Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT00650039 Org: User:
Start: 03/31/04 End: 02/28/05 Due: 02/28/06

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

Phase: N/A Priority: Normal
NCT ID: NCT00002082 Org: User:
Start: - End: - Due: -

Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04574362 Org: User:
Start: 10/22/20 End: 12/16/21 Due: 12/16/22

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00635401 Org: User:
Start: 05/31/04 End: 08/31/04 Due: 08/31/05

A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01105533 Org: User:
Start: 05/31/06 End: 09/30/11 Due: 09/30/12

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Phase: N/A Priority: Normal
NCT ID: NCT01416194 Org: User:
Start: 07/25/11 End: 04/30/19 Due: 04/30/20

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00161928 Org: User:
Start: 04/30/02 End: 01/31/03 Due: 01/31/04

Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01351129 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12